Efficacy and Safety of Olokizumab in Patients With Polymyalgia Rheumatica (PROMISE)

NCT07670546 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Polymyalgia Rheumatica

Interventions

BIOLOGICAL: Olokizumab
DRUG: Placebo

Sponsor

R-Pharm International, LLC